Dyadic International, Inc. (DYAI)
0.3401
-0.03
(-7.25%)
USD |
NASDAQ |
Nov 05, 16:00
Dyadic International EPS Diluted (Quarterly) : -0.0583 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0583 |
| March 31, 2026 | -0.0537 |
| December 31, 2025 | -0.0433 |
| September 30, 2025 | -0.0573 |
| June 30, 2025 | -0.0596 |
| March 31, 2025 | -0.0678 |
| December 31, 2024 | -0.052 |
| September 30, 2024 | -0.0069 |
| June 30, 2024 | -0.0698 |
| March 31, 2024 | -0.0697 |
| December 31, 2023 | -0.0719 |
| September 30, 2023 | -0.056 |
| June 30, 2023 | -0.0747 |
| March 31, 2023 | -0.0332 |
| December 31, 2022 | -0.0752 |
| September 30, 2022 | -0.0637 |
| June 30, 2022 | -0.1163 |
| March 31, 2022 | -0.0882 |
| December 31, 2021 | -0.1493 |
| September 30, 2021 | -0.0611 |
| June 30, 2021 | -0.1391 |
| March 31, 2021 | -0.1197 |
| December 31, 2020 | -0.0713 |
| September 30, 2020 | -0.091 |
| June 30, 2020 | -0.0965 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0806 |
| December 31, 2019 | -0.0635 |
| September 30, 2019 | -0.0625 |
| June 30, 2019 | -0.1005 |
| March 31, 2019 | -0.0814 |
| December 31, 2018 | -0.0192 |
| September 30, 2018 | -0.0554 |
| June 30, 2018 | -0.06 |
| March 31, 2018 | -0.0726 |
| December 31, 2017 | -0.0483 |
| September 30, 2017 | -0.05 |
| June 30, 2017 | -0.05 |
| March 31, 2017 | 0.07 |
| December 31, 2016 | -0.06 |
| September 30, 2016 | -0.03 |
| June 30, 2016 | 0.01 |
| March 31, 2016 | -0.02 |
| December 31, 2015 | -0.1555 |
| September 30, 2015 | 0.06 |
| June 30, 2015 | -0.01 |
| March 31, 2015 | -0.01 |
| December 31, 2014 | -0.0493 |
| September 30, 2014 | -0.03 |
| June 30, 2014 | -0.05 |
| March 31, 2014 | -0.05 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.1417 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.124M |
| Revenue (Quarterly) | 0.9611M |
| Total Expenses (Quarterly) | 3.085M |
| Enterprise Value | 12.77M |
| Gross Profit Margin (Quarterly) | -2.39% |
| Profit Margin (Quarterly) | -221.0% |
| Earnings Yield | -62.51% |
| Normalized Earnings Yield | -62.51 |